Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Ultrasonic Blood Test Method Shows High Accuracy for Alzheimer's Detection

25 August 2026 · By · Wire by Fusion42

Published

25 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

China

◆ Source

Read at clpmag.com →

◆ Verified

Fusion42 · 25 August 2026 · Fusion42 review

A new ultrasonic blood test method using real-time protein misfolding cyclic amplification technology has demonstrated over 90% accuracy in diagnosing Alzheimer's disease in a large validation study conducted in China.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now tap into a new market for minimally invasive, rapid Alzheimer's screening tools with diagnostic performance surpassing traditional methods. Scaling this could unlock early diagnosis and create demand for complementary therapeutic solutions.

◆ Coverage

1 source · 25 Aug 2026

◆ Related on Wire

◆ Topics

Medtechalzheimersdiagnosticsblood-testmedtechultrasonic-pmca